Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anlotinib in advanced solid tumors
CTR20150333Phase 2Completed
- Sponsor
- Chia Tai-Tianqing Pharmaceutical Group
- Start
- Jul 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of anlotinib in Nonhematologic neoplasms, gynecological cancer, breast cancer, gastrointestinal cancer, melanoma, sponsored by Chia Tai-Tianqing Pharmaceutical Group. Started Jul 2015; status: completed.
02
Drugs
anlotinib
03
Conditions
Nonhematologic neoplasmsgynecological cancerbreast cancergastrointestinal cancermelanoma
Beyond the preview
Go deeper on CTR20150333.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20150333.